Redefining the Reference Interval and Cut-Off Values of the Hematological and Biochemical Parameters and Deriving a

Suprava Patel1, Diksha Chandrakar1, Preetam N Wasnik2

  • 1Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh India.

The heterogeneity in clinical presentations in sickle cell disease (SCD) alters between crisis and steady state phases. Considering the pathophysiology, it is crucial to establish a disease-specific reference interval for hematological and biochemical parameters and identify the sensitive predictive markers for crisis. The case-control study included fifty-four healthy control, forty SCD cases in crisis state, and forty-six steady state cases. Blood samples were evaluated for complete blood count (CBC) and biochemical parameters. Red cell indices were calculated. 2.5th and 97.5th percentile values were delineated in the steady state cases as new reference interval. The new cut-off values were evaluated for sensitivity and specificity. The steady state cases reported a significant decrease in urea, sodium, Hb, Hct, and RBC count compared to the control group, whereas potassium, and red cell indices were higher. Compared to the steady state, the crisis state depicted a significant increase in urea, liver enzymes, leucocytes, inflammatory indices, and all red cell indices, whereas sodium, albumin, iron, Hb, Hct, and LMR were decreased. The revised 95 percentile ranges were sodium-132.35-143.65 mmol/L, potassium-3.75-6.09 mmol/L, albumin-2.9-5.0 g/dL, Hb-7.51-12.17 g/dL, RBC count-2.2-5.49 × 106/µL, and Hct-22.54-36.1%. Red cell indices like Ricerca, Green and King, and Huber-Heklotz could be good screening tools for crisis events with more than 70% sensitivity. Thus, the laboratory must derive a new reference interval and cut-off values at the steady state in the SCD population it is catering samples rather than comparing it with normal healthy individuals.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
55
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K